Renal effects of canagliflozin in patients with Type 2 diabetes

被引：0
|
作者：
Wong, Yip Fong [1 ]
Shao, Yanli [1 ]
Sum, Chee Fang [1 ]
机构：
[1] Khoo Teck Puat Hosp, Ctr Diabet, Singapore, Singapore
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-90
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [1] Renal effects of canagliflozin in type 2 diabetes mellitus
    Perkovic, Vlado
    Jardine, Meg
    Vijapurkar, Ujjwala
    Meininger, Gary
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (12) : 2219 - 2231
  • [2] Effects of canagliflozin on serum magnesium in patients with type 2 diabetes
    Gilbert, R.
    Mende, C.
    Vijapurkar, U.
    Sha, S.
    Davies, M. J.
    Desai, M.
    DIABETOLOGIA, 2016, 59 : S350 - S351
  • [3] Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
    Perkovic, V.
    Jardine, M. J.
    Neal, B.
    Bompoint, S.
    Heerspink, H. J. L.
    Charytan, D. M.
    Edwards, R.
    Agarwal, R.
    Bakris, G.
    Bull, S.
    Cannon, C. P.
    Capuano, G.
    Chu, P. -L.
    De Zeeuw, D.
    Greene, T.
    Levin, A.
    Pollock, C.
    Wheeler, D. C.
    Yavin, Y.
    Zhang, H.
    Zinman, B.
    Meininger, G.
    Brenner, B. M.
    Mahaffey, K. W.
    McGuire, Darren K.
    Holman, Rury
    Home, Philip
    Scharfstein, Dan
    Parfrey, Patrick
    Shahinfar, Shahnaz
    August, Phyllis
    Chang, Tara
    Sinha, Arjun D.
    Januzzi, James
    Kolansky, Daniel
    Amerena, John
    Hillis, Graham
    Gorelick, Philip
    Kissela, Brett
    Kasner, Scott
    Lindley, Richard
    Fulcher, Greg
    Ounadjela, Souhila
    Hufert, Karina
    von Ingersleben, Gabriele
    Gaglia, Jason
    Harris, Ronald
    Hudson, Margo
    Turchin, Alexander
    Cheifetz, Adam
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2295 - 2306
  • [4] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Fernandez-Balsells, M. Merce
    Sojo-Vega, Lidia
    Ricart-Engel, Wifredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2098 - 2098
  • [5] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Neal, Bruce
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    de Zeeuw, Dick
    Fulcher, Greg
    Erondu, Ngozi
    Shaw, Wayne
    Law, Gordon
    Desai, Mehul
    Matthews, David R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 644 - 657
  • [6] Canagliflozin and cardiovascular and renal events in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2018, 130 (02) : 149 - 153
  • [7] Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes
    Li, JingWei
    Woodward, Mark
    Perkovic, Vlado
    Figtree, Gemma A.
    Heerspink, Hiddo J. L.
    Mahaffey, Kenneth W.
    de Zeeuw, Dick
    Vercruysse, Frank
    Shaw, Wayne
    Matthews, David R.
    Neal, Bruce
    JACC-HEART FAILURE, 2020, 8 (01) : 57 - 66
  • [8] Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
    Watts, Nelson B.
    Bilezikian, John P.
    Usiskin, Keith
    Edwards, Robert
    Desai, Mehul
    Law, Gordon
    Meininger, Gary
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (01): : 156 - 165
  • [9] Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes
    Li, JingWei
    Neal, Bruce
    Perkoyic, Vlado
    de Zeeuw, Dick
    Neuen, Brendon L.
    Arnott, Clare
    Simpson, Roger
    Oh, Richard
    Mahaffey, Kenneth W.
    Heerspink, Hiddo J. L.
    KIDNEY INTERNATIONAL, 2020, 98 (03) : 769 - 777
  • [10] Safety of Canagliflozin in Patients with Type 2 Diabetes
    Mikhail, Nasser
    CURRENT DRUG SAFETY, 2014, 9 (02) : 127 - 132
12345